Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Glycerol
Haleon UK Ltd
n/a
Glycerol
250mg/1gram
Cutaneous cream
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13020100; GTIN: 5000347089992 5000347001024
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON 1. NAME OF THE MEDICINAL PRODUCT Eumocream ® 25% w/w glycerol 2. STATEMENT OF ACTIVE SUBSTANCE(S) ACTIVE INGREDIENT The cream contains Glycerol 25% w/w. 3. LIST OF EXCIPIENTS OTHER INGREDIENTS Glycerol monostearate 40-55, cetostearyl alcohol, beeswax substitute 6621 (paraffin wax, vegetable stearic acid, prime yellow carnauba wax), arlacel 165 (glycerol monostearate, polyoxyethylene 100 stearate), dimeticone, chlorocresol, sodium citrate, citric acid monohydrate and purified water. 4. PHARMACEUTICAL FORM AND CONTENTS Cream 100 g 5. METHOD AND ROUTE(S) OF ADMINISTRATION _ _ HOW TO USE EUMOCREAM Use this medicine only on your skin. Apply the cream to the affected skin as needed. Eumocream can be used on all areas of the body including the face. 6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN KEEP OUT OF THE SIGHT AND REACH OF CHILDREN. 7. OTHER SPECIAL WARNING(S), IF NECESSARY PLEASE READ RIGHT THROUGH THIS INFORMATION CAREFULLY BEFORE YOU START USING THIS MEDICINE. CHECK BEFORE YOU USE DO NOT USE EUMOCREAM: • if you have ever had an ALLERGIC reaction to glycerol or to any of the other ingredients (see Further information). TAKE SPECIAL CARE WITH EUMOCREAM • AVOID CONTACT WITH THE EYES. • Talk to your doctor before using the cream if you are PREGNANT or BREAST- FEEDING. If your symptoms persist, SEE YOUR DOCTOR. Do not smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it. POSSIBLE SIDE EFFECTS Like all medicines, Eumocream can have side effects, such as local skin reactions, but these are rare. REPORTING OF SIDE EFFECTS If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this carton. You can also report side effects direc Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Eumocream 25% w/w 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Glycerol 25% w/w For excipients, see 6.1 3 PHARMACEUTICAL FORM Cream Smooth, white cream 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This product is indicated for the management of dry or flaky skin conditions which may also be pruritic such as eczema or dermatitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For topical application to the skin. Adults, the elderly, infants, babies and children: The cream should be applied to the affected areas as often as required. 4.3 CONTRAINDICATIONS Hypersensitivity to any of the ingredients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Avoid contact with the eyes, as the product may cause irritation to the epithelial cells of the cornea. Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None stated 4.6 PREGNANCY AND LACTATION Animal studies are insufficient with respect to effects on pregnancy, foetal development, parturition or postnatal developments. The potential risk for humans is unknown. Caution should be exercised when prescribing to pregnant women. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES None stated 4.8 UNDESIRABLE EFFECTS Hypersensitivity reactions have been rarely reported; they usually consist of localised skin reactions. REPORTING OF SUSPECTED ADVERSE REACTIONS Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:www.mhra.gov.uk/yellowcard. 4.9 OVERDOSE Eumocream is of low Read the complete document